KATHRYN BILYEU, APRN
Family Nurse Practitioner · OVERLAND PARK, KS
Individual Active NPI 1306517891
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 190 | 90,483 | $9,638,832 | $3,793,426 | $3,021,788 |
| 2023 | 31 | 4,529 | $150,987 | $76,771 | $60,683 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 10,200 | $22 | $18 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 5,880 | $18 | $14 |
| J2357 | Injection, omalizumab, 5 mg | 5,610 | $38 | $30 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 4,500 | $18 | $14 |
| J3245 | Injection, tildrakizumab, 1 mg | 1,900 | $134 | $107 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,370 | $31 | $25 |
| J0517 | Injection, benralizumab, 1 mg | 960 | $165 | $131 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 770 | $0 | $0 |
| 96372 | Injection of drug or substance under skin or into muscle | 324 | $11 | $9 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 126 | $48 | $38 |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 95 | $16 | $13 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 81 | $98 | $78 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 53-80545-052 | KS |
| Family Nurse Practitioner | 363LF0000X | 2021018045 | MO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Kansas
- NPI 1467945618
- NPI 1831973056
- NPI 1215653944
- NPI 1073890661
- NPI 1003372327
- NPI 1710454855
- NPI 1518594787
- NPI 1265063929
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.